Ligand validation:6I23

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I23_EDO_A_405	22%	88%	0.255	0.869	0.45	0.23	-	-	0	0	100%	1
6I23_EDO_B_407	21%	88%	0.239	0.846	0.52	0.17	-	-	0	0	100%	1
6I23_EDO_A_404	8%	87%	0.272	0.743	0.42	0.29	-	-	1	0	100%	1
6I23_EDO_A_406	5%	89%	0.462	0.878	0.43	0.21	-	-	2	0	100%	1
6I23_EDO_B_406	2%	89%	0.27	0.524	0.51	0.15	-	-	0	0	100%	1
6I23_EDO_B_405	1%	86%	0.248	0.449	0.63	0.11	-	-	0	0	100%	1
6I24_EDO_A_404	83%	70%	0.096	0.955	0.68	0.5	-	-	1	0	100%	0.5
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.